Preliminary evaluation of a fixed dose of zwitterionic piperazine (TVZ- 7) in clinical cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 12, Issue 5, 1997, Pages 351-353

  Theodore, T Ronald ^a   Van Zandt, Roscoe L ^b   Carpenter, Robert H ^b  

^a Intgd Biologies Res Labs Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; DOXORUBICIN; HYDROMORPHONE; IBUPROFEN; MORPHINE;

ADULT; ANTINOCICEPTION; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER PAIN; CANCER RADIOTHERAPY; CARDIOTOXICITY; CASE REPORT; CELL PROLIFERATION; DRUG CONFORMATION; DRUG EFFECT; DRUG EFFICACY; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

EID: 0031439495     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1997.12.351     Document Type: Article

References (3)

1. Good NE, Widget GD, Winter W, Connolly TN, Izawa S, and Singh RMM. Hydrogen ions: Buffers for biological research. Biochemistry 1966;5:467.
2. Stapleton PP, Mahon TM, Nowlan P, and Bloomfield FJ. Effects of in vivo administration of taurine and HEPES on the inflammatory response in rats. Pharmacy and Pharmacology 1994;46(9):745.
3. Theodore RT, VanZandt RL, and Carpenter RH. Pilot ascending dose tolerance study of parenterally administered 4(2 Hydroxyethyl)-1-piperazine ethane sulfonic acid (TVZ-7) in dogs. Cancer Biother & Radiopharm 1997;12(5):345-349.